In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer recurrence by approximately 55% in patients with specific PI3K pathway mutations.

Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase 3 ...

PI3K Pathway Aberrations May Reveal Targeted Therapy Opportunities Combination therapies targeting both mutations in the PI3K pathway and HER2 or hormone receptor overexpression should be evaluated, ...

A new study has revealed that a common over-the-counter medication, aspirin, can cut the risk of colorectal cancer recurrence ...

A clinical trial called ALASCCA, which has been published in The New England Journal of Medicine, shows that patients with ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus. The study shows that ...

Hypertrophic cardiomyopathy (HCM) is an inherited disease characterized by diastolic dysfunction, fibrosis, and asymmetric ...

A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...